The closing price of Inovio Pharmaceuticals Inc (NASDAQ: INO) was $0.40 for the day, up 1.28% from the previous closing price of $0.39. In other words, the price has increased by $+0.0050 from its previous closing price. On the day, 2845788 shares were traded. INO stock price reached its highest trading level at $0.4322 during the session, while it also had its lowest trading level at $0.3841.
Our analysis of INO’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.91 and its Current Ratio is at 3.91. In the meantime, Its Debt-to-Equity ratio is 0.18 whereas as Long-Term Debt/Eq ratio is at 0.07.
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jun 05 when Zoth Lota S. sold 5,700 shares for $0.56 per share. The transaction valued at 3,192 led to the insider holds 52,716 shares of the business.
Weiner David B. sold 5,833 shares of INO for $6,708 on Mar 13. The Director now owns 910,124 shares after completing the transaction at $1.15 per share. On Feb 27, another insider, Weiner David B., who serves as the Director of the company, sold 11,668 shares for $1.28 each. As a result, the insider received 14,935 and left with 904,291 shares of the company.
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INO now has a Market Capitalization of 105.89M and an Enterprise Value of -58.27M. For the stock, the TTM Price-to-Sale (P/S) ratio is 11.01 while its Price-to-Book (P/B) ratio in mrq is 0.63. Its current Enterprise Value per Revenue stands at -6.06 whereas that against EBITDA is 0.36.
Stock Price History:
Over the past 52 weeks, INO has reached a high of $2.61, while it has fallen to a 52-week low of $0.34. The 50-Day Moving Average of the stock is 0.4206, while the 200-Day Moving Average is calculated to be 0.7443.
INO traded an average of 3.45M shares per day over the past three months and 2.63M shares per day over the past ten days. A total of 268.07M shares are outstanding, with a floating share count of 263.72M. Insiders hold about 1.62% of the company’s shares, while institutions hold 26.94% stake in the company. Shares short for INO as of Oct 12, 2023 were 25.71M with a Short Ratio of 25.71M, compared to 15.63M on Sep 14, 2023. Therefore, it implies a Short% of Shares Outstanding of 9.59% and a Short% of Float of 10.95%.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.00%, it implies a Forward Annual Dividend Yield of 1.52%.
The firm’s stock currently is rated by 3 analysts. On average, analysts expect EPS of -$0.13 for the current quarter, with a high estimate of -$0.12 and a low estimate of -$0.13, while EPS last year was -$0.15. The consensus estimate for the next quarter is -$0.13, with high estimates of -$0.1 and low estimates of -$0.16.
Analysts are recommending an EPS of between -$0.53 and -$0.58 for the fiscal current year, implying an average EPS of -$0.55. EPS for the following year is -$0.33, with 3 analysts recommending between -$0.21 and -$0.4.
A total of 3 analysts have provided revenue estimates for INO’s current fiscal year. The highest revenue estimate was $800k, while the lowest revenue estimate was $300k, resulting in an average revenue estimate of $580k. In the same quarter a year ago, actual revenue was $10.26M, down -94.30% from the average estimate.